


The Fund aims to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 4.7% |
| GlaxoSmithKline PLC | 4.6% |
| Royal Dutch Shell PLC | 4.1% |
| BG Group PLC | 3.9% |
| Rio Tinto PLC | 3.3% |
| British American Tobacco PLC | 3.0% |
| HSBC Holdings PLC | 2.7% |
| BT Group PLC | 2.5% |
| Standard Chartered PLC | 2.4% |
| Royal Dutch Shell PLC | 2.4% |
| Key | % Net Assets |
|---|---|
| 4.7% | |
| 4.6% | |
| 4.1% | |
| 3.9% | |
| 82.7% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 215.83 |
| Currency | EUR |
| Change | 0.51 |
| % | 0.24% |
| YTD change | 16.34 |
| YTD % | 8.19% |
| Fund Inception | 01/07/2002 |
|---|---|
| Fund Manager | Dominic Baker |
| TER | 1.67 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | 500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.05 |
You are here: research